AMED Amedisys: Company Value to Revenue Ratio

Public company logo of Amedisys Health (AMED)

Steady growth of the aging population provides Amedisys, Inc. (AMED) with a constant inflow of capital. This chart on GURU.Markets displays the company's EV-to-revenue multiple, where the value serves as the target level. The business generates revenue from hospices and home care for chronically ill patients, relying on its own nursing staff and minimizing third-party outsourcing.

Amedisys Inc (AMED) Company Value to Revenue: for the period 07/04/2022 - 11/20/2026

AMED (Amedisys): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental company valuation:AMED, Amedisys Inc
Mass-produced product of amedisys.com

The EV/Sales ratio determines the enterprise value of the business, including net debt, per unit of revenue, allowing the investor to assess revenue generation efficiency without distortions from the financing structure. The current value of and the EV/Sales trend reflect market confidence in Paul Kusick's operational expertise in managing healthcare quality and implementing new technologies into Amedisys, Inc. (AMED) services.